Cardinal Health Company Profile (NYSE:CAH)

About Cardinal Health

Cardinal Health logoCardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs Wholesale
  • Sub-Industry: Health Care Distributors
  • Exchange: NYSE
  • Symbol: CAH
  • CUSIP: 14149Y10
Key Metrics:
  • Previous Close: $80.24
  • 50 Day Moving Average: $74.76
  • 200 Day Moving Average: $75.73
  • 52-Week Range: $315,454,000.00 - $62.70
  • Trailing P/E Ratio: 19.43
  • Foreward P/E Ratio: 13.59
  • P/E Growth: 1.61
  • Market Cap: $25.46B
  • Outstanding Shares: 315,454,000
  • Beta: 0.71
  • Net Margins: 1.06%
  • Return on Equity: 25.52%
  • Return on Assets: 4.85%
  • Debt-to-Equity Ratio: 0.77%
  • Current Ratio: 1.10%
  • Quick Ratio: 0.53%
Additional Links:
Companies Related to Cardinal Health:

Analyst Ratings

Consensus Ratings for Cardinal Health (NYSE:CAH) (?)
Ratings Breakdown: 11 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.31)
Consensus Price Target: $89.50 (10.89% upside)

Analysts' Ratings History for Cardinal Health (NYSE:CAH)
DateFirmActionRatingPrice TargetDetails
2/8/2017Leerink SwannSet Price TargetHold$81.00View Rating Details
1/3/2017MizuhoDowngradeBuy -> Neutral$79.00View Rating Details
11/14/2016Barclays PLCSet Price TargetBuy$88.00View Rating Details
10/28/2016Robert W. BairdDowngradeOutperform -> Neutral$92.00 -> $82.00View Rating Details
10/10/2016Cleveland ResearchDowngradeBuy -> NeutralView Rating Details
9/19/2016Bank of America CorpReiterated RatingHold$90.00View Rating Details
9/16/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$90.00 -> $83.00View Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$91.00View Rating Details
8/30/2016Credit Suisse GroupReiterated RatingBuy$97.00View Rating Details
8/4/2016Deutsche Bank AGBoost Price TargetHold$83.00 -> $89.00View Rating Details
8/3/2016Citigroup Inc.Boost Price TargetNeutral$87.00 -> $93.00View Rating Details
6/20/2016FBR & CoReiterated RatingBuyView Rating Details
6/13/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
6/1/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
4/18/2016Avondale PartnersInitiated CoverageOutperform$111.00View Rating Details
3/15/2016Cowen and CompanyDowngradeOutperform -> Market Perform$99.00 -> $90.00View Rating Details
2/2/2016William BlairReiterated RatingOutperformView Rating Details
7/14/2015Evercore ISIDowngradeBuy -> Hold$91.50View Rating Details
3/3/2015ArgusBoost Price TargetBuy$90.00 -> $105.00View Rating Details
(Data available from 2/19/2015 forward)


Earnings History for Cardinal Health (NYSE:CAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2017Q217$1.23$1.34$33.63 billion$33.10 billionViewListenView Earnings Details
10/31/2016Q117$1.21$1.24$31.12 billion$32.00 billionViewListenView Earnings Details
8/2/2016Q416$1.13$1.14$31.06 billion$31.40 billionViewN/AView Earnings Details
4/28/2016Q316$1.33$1.43$30.54 billion$30.70 billionViewListenView Earnings Details
2/1/2016Q216$1.26$1.30$29.23 billion$31.40 billionViewN/AView Earnings Details
11/2/2015Q116$1.10$1.38$27.19 billion$28.10 billionViewN/AView Earnings Details
7/30/2015Q415$0.99$1.00$26.05 billion$27.50 billionViewListenView Earnings Details
4/30/2015Q3$1.16$1.19$24.40 billion$25.38 billionViewN/AView Earnings Details
1/29/2015Q215$1.10$1.20$23.43 billion$25.50 billionViewN/AView Earnings Details
10/30/2014Q115$0.96$1.00$22.43 billion$24.07 billionViewN/AView Earnings Details
8/4/2014Q414$0.81$0.83$21.88 billion$2.90 billionViewN/AView Earnings Details
5/1/2014Q314$1.01$1.01$21.72 million$21.40 millionViewN/AView Earnings Details
1/31/2014Q214$0.84$0.79$20.74 billion$22.20 billionViewN/AView Earnings Details
10/31/2013Q114$0.86$1.10$22.73 billion$24.50 billionViewN/AView Earnings Details
8/1/2013Q4 2013$0.77$0.79$24.56 billion$25.40 billionViewN/AView Earnings Details
5/2/2013Q3 2013$0.95$1.20$24.72 billion$24.60 billionViewN/AView Earnings Details
2/5/2013Q2 2013$0.86$0.93$24.61 million$22.75 millionViewN/AView Earnings Details
10/30/2012Q113$0.79$0.81$26.33 million$25.90 millionViewN/AView Earnings Details
8/2/2012$0.73$0.73ViewN/AView Earnings Details
5/3/2012$0.88$0.94ViewN/AView Earnings Details
2/2/2012$0.77$0.81ViewN/AView Earnings Details
10/27/2011$0.72$0.73ViewN/AView Earnings Details
8/4/2011$0.58$0.59ViewN/AView Earnings Details
4/28/2011$0.69$0.75ViewN/AView Earnings Details
2/3/2011$0.61$0.69ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cardinal Health (NYSE:CAH)
Current Year EPS Consensus Estimate: $5.42 EPS
Next Year EPS Consensus Estimate: $5.94 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.31$1.37$1.33
Q2 20165$1.27$1.33$1.30
Q3 20163$1.33$1.46$1.41
Q4 20165$1.12$1.51$1.35
Q1 20173$1.21$1.26$1.23
Q2 20173$1.20$1.33$1.26
Q3 20173$1.43$1.60$1.50
Q4 20173$1.36$1.41$1.39
Q1 20181$1.34$1.34$1.34
Q2 20181$1.42$1.42$1.42
Q3 20181$1.59$1.59$1.59
Q4 20181$1.56$1.56$1.56
(Data provided by Zacks Investment Research)


Current Dividend Information for Cardinal Health (NYSE:CAH)
Annual Dividend:$1.80
Dividend Yield:2.23%
Dividend Growth:13.10% (3 Year Average)
Payout Ratio:43.17% (Based on Trailing 12 Months of Earnings)
33.21% (Based on Current Year Consensus EPS Estimate)
30.30% (Based on Next Year Consensus EPS Estimate)
Track Record:12 Years of Consecutive Dividend Growth

Dividend History for Cardinal Health (NYSE:CAH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Cardinal Health (NYSE:CAH)
Insider Ownership Percentage: 0.94%
Institutional Ownership Percentage: 85.84%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/10/2017George S BarrettChairmanSell217,994$77.23$16,835,676.62View SEC Filing  
11/10/2016George S BarrettChairmanSell217,995$71.29$15,540,863.55View SEC Filing  
8/18/2016Patricia MorrisonInsiderSell43,959$82.50$3,626,617.50View SEC Filing  
8/18/2016Stuart G LawsSVPSell9,703$82.45$800,012.35View SEC Filing  
8/16/2016Jon L GiacominCEOSell47,251$82.77$3,910,965.27View SEC Filing  
8/11/2016Craig S MorfordInsiderSell12,697$83.13$1,055,501.61View SEC Filing  
8/10/2016Donald M Jr. CaseyCEOSell59,180$83.59$4,946,856.20View SEC Filing  
8/10/2016George S BarrettChairmanSell250,000$83.63$20,907,500.00View SEC Filing  
8/9/2016George S BarrettCEOSell129,818$83.76$10,873,555.68View SEC Filing  
8/8/2016George S BarrettCEOSell20,428$83.75$1,710,845.00View SEC Filing  
5/20/2016Carole S WatkinsInsiderSell84,617$77.33$6,543,432.61View SEC Filing  
11/6/2015Falk T. StephenEVPSell30,085$87.66$2,637,251.10View SEC Filing  
8/20/2015George S. BarrettCEOSell300,000$83.08$24,924,000.00View SEC Filing  
5/12/2015Falk T StephenEVPSell39,428$86.12$3,395,539.36View SEC Filing  
5/11/2015George S BarrettCEOSell300,000$86.44$25,932,000.00View SEC Filing  
3/4/2015Colleen F ArnoldDirectorSell9,801$87.65$859,057.65View SEC Filing  
3/3/2015Richard C NotebaertDirectorSell9,801$88.20$864,448.20View SEC Filing  
2/20/2015Carole S WatkinsInsiderSell33,847$87.00$2,944,689.00View SEC Filing  
2/10/2015Carole S WatkinsInsiderSell50,770$85.00$4,315,450.00View SEC Filing  
2/10/2015George S BarrettCEOSell300,000$84.87$25,461,000.00View SEC Filing  
11/7/2014Mark R BlakeEVPSell24,668$79.50$1,961,106.00View SEC Filing  
9/5/2014Carole S WatkinsInsiderSell40,794$75.00$3,059,550.00View SEC Filing  
9/4/2014Michael C KaufmannCEOSell50,216$74.95$3,763,689.20View SEC Filing  
8/27/2014Jeffrey William HendersonCFOSell26,567$72.63$1,929,561.21View SEC Filing  
8/18/2014Jeffrey William HendersonCFOSell78,637$72.06$5,666,582.22View SEC Filing  
8/18/2014Mark R BlakeEVPSell4,782$72.15$345,021.30View SEC Filing  
8/18/2014Michael C KaufmannCEOSell6,833$72.06$492,385.98View SEC Filing  
8/8/2014Craig S MorfordInsiderSell43,359$70.03$3,036,430.77View SEC Filing  
8/8/2014Jeffrey William HendersonCFOSell118,093$69.72$8,233,443.96View SEC Filing  
7/24/2014Mark R BlakeEVPSell23,114$73.41$1,696,798.74View SEC Filing  
7/24/2014Stuart G LawsCAOSell21,266$72.50$1,541,785.00View SEC Filing  
7/14/2014Jeffrey William HendersonCFOSell23,632$70.65$1,669,600.80View SEC Filing  
5/19/2014Mark BlakeEVPSell4,703$66.50$312,749.50View SEC Filing  
5/13/2014Mark BlakeEVPSell2,822$66.50$187,663.00View SEC Filing  
5/7/2014Jeffrey William HendersonCFOSell27,031$63.83$1,725,388.73View SEC Filing  
2/11/2014Mark BlakeEVPSell2,330$68.53$159,674.90View SEC Filing  
2/11/2014Michael KaufmannCEOSell388,995$67.46$26,241,602.70View SEC Filing  
2/10/2014George BarrettCEOSell200,000$66.64$13,328,000.00View SEC Filing  
2/5/2014Gregory KennyDirectorSell18,175$65.39$1,188,463.25View SEC Filing  
2/4/2014Carole WatkinsInsiderSell46,666$65.71$3,066,422.86View SEC Filing  
2/4/2014Falk StephenEVPSell17,926$65.56$1,175,228.56View SEC Filing  
2/4/2014Richard NotebaertDirectorSell10,727$65.68$704,549.36View SEC Filing  
11/11/2013George BarrettCEOSell200,000$62.71$12,542,000.00View SEC Filing  
9/11/2013Mark R BlakeEVPSell14,584$51.53$751,513.52View SEC Filing  
8/19/2013Mark BlakeEVPSell4,925$51.27$252,504.75View SEC Filing  
8/16/2013Falk StephenEVPSell10,000$51.50$515,000.00View SEC Filing  
8/15/2013Craig MorfordInsiderSell20,000$51.33$1,026,600.00View SEC Filing  
8/13/2013George BarrettCEOSell75,000$52.09$3,906,750.00View SEC Filing  
8/13/2013Jeffrey William HendersonCFOSell54,590$51.99$2,838,134.10View SEC Filing  
8/8/2013Calvin DardenDirectorSell3,254$51.48$167,515.92View SEC Filing  
8/5/2013Mark BlakeEVPSell29,166$51.53$1,502,923.98View SEC Filing  
7/26/2013Jeffrey William HendersonCFOSell76,781$50.99$3,915,063.19View SEC Filing  
7/18/2013Jeffrey William HendersonCFOSell57,623$49.99$2,880,573.77View SEC Filing  
7/15/2013Jeffrey William HendersonCFOSell14,660$49.99$732,853.40View SEC Filing  
7/11/2013Jeffrey William HendersonCFOSell83,211$48.99$4,076,506.89View SEC Filing  
6/19/2013John F FinnDirectorSell11,070$48.51$537,005.70View SEC Filing  
5/28/2013Jean G SpauldingDirectorSell8,350$47.35$395,372.50View SEC Filing  
5/22/2013Richard C NotebaertDirectorSell3,197$48.10$153,775.70View SEC Filing  
5/20/2013Carole S WatkinsInsiderSell4,612$48.00$221,376.00View SEC Filing  
5/20/2013Jean G SpauldingDirectorSell1,666$47.90$79,801.40View SEC Filing  
11/1/2012Stuart G LawsCAOSell2,564$41.22$105,688.08View SEC Filing  
10/4/2012Jeffrey William HendersonCFOSell46,226$40.00$1,849,040.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cardinal Health (NYSE:CAH)
News IconBuy, Sell or Hold? Analysts Approach: Cardinal Health, Inc. (CAH), TD Ameritrade Holding Corporation (AMTD)? - The USA Commerce (NYSE:CAH) - February 17 at 6:05 PM logoOhio companies lauded for inclusive practices (NYSE:CAH) - February 17 at 6:05 PM logoSurvey Finds Hospital Staff Report Better Supply Chain Management Leads to Better Quality of Care and Supports Patient Safety (NYSE:CAH) - February 16 at 8:59 AM logoInsider Trading Activity Cardinal Health, Inc. (NYSE:CAH) – Chairman Sold 217,994 shares of Stock (NYSE:CAH) - February 14 at 4:46 PM logoETFs with exposure to Cardinal Health, Inc. : February 14, 2017 (NYSE:CAH) - February 14 at 4:46 PM
News IconIs this Large Market Cap Stock target price reasonable for Cardinal Health, Inc. (NYSE:CAH)? (NYSE:CAH) - February 12 at 9:09 PM logoCARDINAL HEALTH INC Financials (NYSE:CAH) - February 11 at 4:12 PM
News IconSell-Side Analyst's Predictions: The PNC Financial Services Group, Inc. (PNC), Cardinal Health, Inc. (CAH) - The USA Commerce (NYSE:CAH) - February 10 at 3:44 PM logoTop Analyst Reports for Morgan Stanley, GM & Prudential (NYSE:CAH) - February 10 at 3:43 PM
News IconShares of Cardinal Health, Inc. (CAH) Sees Large Outflow of Money (NYSE:CAH) - February 9 at 4:24 PM logo5 Stocks For 17% Returns This Year (& Beyond) (NYSE:CAH) - February 9 at 4:23 PM logoCardinal Health, Inc. :CAH-US: Earnings Analysis: Q2, 2017 By the Numbers : February 8, 2017 (NYSE:CAH) - February 8 at 4:21 PM logoCardinal Health revenue misses on generic drug pricing pressure (NYSE:CAH) - February 8 at 3:15 AM logoEdited Transcript of CAH earnings conference call or presentation 7-Feb-17 1:30pm GMT (NYSE:CAH) - February 7 at 10:13 PM logoCardinal Health CEO George Barrett elected to lead corporate health-policy group (NYSE:CAH) - February 7 at 10:13 PM
News IconCardinal Health Again Trims 2017 Profit Forecast (NYSE:CAH) - February 7 at 5:11 PM logoEARNINGS SUMMARY: Details of Cardinal Health Inc Q2 Earnings Report (NYSE:CAH) - February 7 at 5:11 PM logoCardinal Health (CAH) Q2 2017 Results - Earnings Call Transcript (NYSE:CAH) - February 7 at 5:11 PM logoCardinal beats 2Q profit forecasts (NYSE:CAH) - February 7 at 5:11 PM logoCardinal Health quarterly revenue rises about 5 percent (NYSE:CAH) - February 7 at 5:10 PM logoCardinal Health reports Q2 profit beat and revenue miss (NYSE:CAH) - February 7 at 5:10 PM logoMarket Recon: I Have a Nice Problem With Disney (NYSE:CAH) - February 7 at 5:10 PM logo[$$] Cardinal Health Again Trims 2017 Profit Forecast (NYSE:CAH) - February 7 at 5:10 PM logoCardinal Health (CAH) Tops Q2 Earnings, Miss on Revenues (NYSE:CAH) - February 7 at 5:10 PM logoUPDATE 2-Cardinal Health revenue misses on generic drug pricing pressure (NYSE:CAH) - February 7 at 5:10 PM logoCardinal Health wins $2.25B Pentagon contract renewal (NYSE:CAH) - February 6 at 4:08 PM logoCardinal Health wins $2.25 billion US defense contract: Pentagon - (NYSE:CAH) - February 3 at 9:22 PM logoCardinal Health wins $2.25 billion U.S. defense contract: Pentagon (NYSE:CAH) - February 3 at 4:19 PM logoServices Stocks on Investors' Radar -- Cardinal Health, AmerisourceBergen, GNC Holdings, and McKesson - PR Newswire (press release) (NYSE:CAH) - February 2 at 9:20 PM logoCardinal Health wins $2.25 billion US defense contract: Pentagon - Reuters (NYSE:CAH) - February 2 at 9:20 PM logoCardinal Health wins $2.25 bln U.S. defense contract -Pentagon (NYSE:CAH) - February 2 at 9:20 PM logo5:34 pm Cardinal Health and Owens & Minor (OMI (NYSE:CAH) - February 2 at 9:20 PM logoServices Stocks on Investors' Radar -- Cardinal Health, AmerisourceBergen, GNC Holdings, and McKesson (NYSE:CAH) - February 2 at 4:20 PM logoCardinal Health Board of Directors Approves Quarterly Dividend (NYSE:CAH) - February 2 at 4:20 PM logoStocks Highlights: Cardinal Health, Inc. (CAH), Albemarle Corporation (ALB), Citizens Financial Group, Inc. (CFG) - iStreetWire (NYSE:CAH) - February 1 at 3:17 PM
News IconEarnings Forecast Research on Cardinal Health, Inc. (CAH) - Highland Mirror (NYSE:CAH) - February 1 at 3:17 PM
News IconEarnings Parade Rolls On, What Are Analysts Saying About Cardinal Health, Inc. (NYSE:CAH)? - Wall Street Beacon (NYSE:CAH) - February 1 at 2:37 AM
News IconWhat's Ahead For This Dividend Darling: Cardinal Health, Inc. (NYSE:CAH) - Aiken Advocate (NYSE:CAH) - January 31 at 4:32 PM logoCardinal Health (CAH) Q2 Earnings: What's in the Cards? (NYSE:CAH) - January 31 at 4:32 PM logoCardinal Health, Inc. breached its 50 day moving average in a Bearish Manner : CAH-US : January 30, 2017 (NYSE:CAH) - January 30 at 4:08 PM
News IconStock to Watch: Cardinal Health Inc. (CAH) - Market Point (NYSE:CAH) - January 28 at 4:15 PM logoIngersoll-Rand Becomes #172 Most Shorted S&P 500 Component, Replacing Cardinal Health (NYSE:CAH) - January 27 at 10:15 PM
News IconHealthinvest Partners Ab Has Increased Cardinal Health INC (CAH) Stake by $5.45 Million (NYSE:CAH) - January 27 at 10:15 PM logoBlog Coverage Wholesale Drug Distributor McKesson Acquired CoverMyMeds (NYSE:CAH) - January 27 at 10:15 PM logoA look at the status of the death penalty in several states (NYSE:CAH) - January 27 at 10:15 PM logoMore delays in executions as some states find lethal drugs (NYSE:CAH) - January 27 at 2:59 AM logo3 Trending Stocks: Cardinal Health, Inc. (CAH), Continental Resources, Inc. (CLR), Northern Trust Corporation (NTRS) - iStreetWire (NYSE:CAH) - January 26 at 4:56 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Cardinal Health, Inc. (NYSE:CAH) Stock - Aiken Advocate (NYSE:CAH) - January 25 at 10:14 PM
News IconTraders are Following Technical Levels for Cardinal Health Inc. (CAH) - Market Point (NYSE:CAH) - January 25 at 10:14 PM
News IconEarnings in Full Force, Analysts Take Aim at Cardinal Health, Inc. (NYSE:CAH) - Wall Street Beacon (NYSE:CAH) - January 25 at 10:14 PM


What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health declared a quarterly dividend on Thursday, February 2nd. Stockholders of record on Monday, April 3rd will be given a dividend of $0.4489 per share on Saturday, April 15th. This represents a $1.80 annualized dividend and a dividend yield of 2.22%. The ex-dividend date is Thursday, March 30th.

Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2017?

16 brokers have issued 1 year price targets for Cardinal Health's shares. Their predictions range from $79.00 to $111.00. On average, they expect Cardinal Health's share price to reach $89.50 in the next year.

When will Cardinal Health announce their earnings?

Cardinal Health is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What are analysts saying about Cardinal Health stock?

Here are some recent quotes from research analysts about Cardinal Health stock:

  • According to Zacks Investment Research, "Cardinal Health ended second-quarter fiscal 2017 on a stable note boosted by strong numbers from both the Pharmaceutical and Medical segments. However over the past one year, Cardinal Health underperformed the broader industry with respect to price performance. The company is banking on strategic buyouts (Lymphoseek), joint ventures and supply agreements to drive growth. Cardinal Health also announced that it will bring its powder-free gloves product line to Hong Kong, thus fortifying its footprint in Asia. The company continues to believe that China presents significant growth opportunities. On the flip side, increasing generic pricing pressure remains a major concern for the coming quarters. Moreover, intensifying competition, customer concentration and higher leverage are the primary headwinds. Sluggish macroeconomic situations, competitive markets & a tough product pricing environment are also likely to dent growth." (2/10/2017)

  • Leerink Swann analysts commented, "We were disappointed by the pharmaceutical operating margin of 1.92% (-24 bps y/y) which was below our 2.02%E, though operating income itself was ahead of our estimate. The Medical division revenue was slightly ahead of our model, and operating income of $122M (margin of 3.80% vs. 4.49%E) was roughly in-line. Cordis is seasonal in nature and as a result earnings were good in Medical last quarter. F2017 Outlook Tough but Long-term +10-15% EPS Growth Guidance Good. Management provided F2017 guidance of $5.48-$5.73. The midpoint of guidance of $5.61 is below consensus of $5.69 and CAH indicated that F1Q:17 pharma operating income would decline in the ‘high teens to low twenty percent range,’ though be flat for F2017 relative to F2016. While this would normally be highly worrisome, management did a good job explaining that F1Q:16 EPS grew +38% y/y and the comp. is difficult due largely to generic pricing trends. In CAH’s prepared presentation, and on the call, management highlighted that they ‘aspire’ to grow adjusted EPS by +10-15% y/y over the longer term. Net customer activity and pricing is expected to have a ($0.55) headwind on F2017 results, tied mainly to Safeway, generic deflation, and less incremental earnings from new generic launches and Red Oak." (8/3/2016)

Who owns Cardinal Health stock?

Cardinal Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock, Inc (7.50%), Barrow Hanley Mewhinney & Strauss LLC (6.68%), State Street Corp (5.19%), Vulcan Value Partners LLC (1.37%), FMR LLC (1.26%) and Franklin Resources Inc. (0.67%). Company insiders that own Cardinal Health stock include Carole S Watkins, Colleen F Arnold, Craig S Morford, Donald M Jr Casey, Falk T Stephen, George S Barrett, Jon L Giacomin, Patricia Morrison, Richard C Notebaert and Stuart G Laws.

Who sold Cardinal Health stock? Who is selling Cardinal Health stock?

Cardinal Health's stock was sold by a variety of institutional investors in the last quarter, including FIL Ltd, Janus Capital Management LLC, AQR Capital Management LLC, FMR LLC, Raymond James Financial Services Advisors Inc., Artemis Investment Management LLP, Foresters Investment Management Company Inc. and NN Investment Partners Holdings N.V.. Company insiders that have sold Cardinal Health stock in the last year include Carole S Watkins, Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws.

Who bought Cardinal Health stock? Who is buying Cardinal Health stock?

Cardinal Health's stock was purchased by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Vulcan Value Partners LLC, Franklin Resources Inc., DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Russell Investments Group Ltd., Credit Agricole S A, State Street Corp and Southpoint Capital Advisors LP.

How do I buy Cardinal Health stock?

Shares of Cardinal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cardinal Health stock cost?

One share of Cardinal Health stock can currently be purchased for approximately $80.71.

Cardinal Health (NYSE:CAH) Chart for Sunday, February, 19, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Earnings History Chart

Earnings by Quarter for Cardinal Health (NYSE:CAH)

Dividend History Chart

Dividend Payments by Quarter for Cardinal Health (NYSE:CAH)

Last Updated on 2/19/2017 by Staff